“Our first handful of cohorts have included companies like Cognition, Chai Discovery, Listen Labs, Physical Intelligence, and Flappy Airplanes.”
Source→“When you look at a model like let's say Chai 1, I think there are 23 distinct sub-modules in Chai 1.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.
“Chai Discovery: AI-native foundation model lab for biology; builds computer-aided design tools for molecule engineering.”
“I really started my career at OpenAI. So it was on the early team there, was a nonprofit back then... We did GPT-1, GPT-2, scaling laws.”
Source→“One of the founding engineers, Kevin Wu, he had the first, I think it was the first protein diffusion model like ever. And that speaks to Kevin's speed of execution.”
Source→“Andy Young... has got 20 years experience in like Pfizer and Genentech, like really honing these methods, has a drug approval to his name in antibodies.”
Source→“Nathan was actually homeschooled and then started college very early on. So he joined like David Baker's lab who won the Nobel Prize for protein design. Like when he was 14, started his PhD when he was 18”
Source→“One of the founding engineers, Kevin Wu, he had the first, I think it was the first protein diffusion model like ever. And that speaks to Kevin's speed of execution.”
Source→“Our co-founder Jack worked at Stripe. Munaz, who was one of the top 10 code contributors at Stripe.”
Source→“Munaz, who was one of the top 10 code contributors at Stripe.”
Source→“A lot of times folks think about Chai and Isomorphic in the same neighborhood. Isomorphic is developing drugs. You guys are enabling the existing industry to develop drugs more efficiently.”
Source→“Chai Discovery raised $400M Series C at $3.8B valuation with an elite syndicate including Sequoia, Kleiner Perkins, General Catalyst, Thrive Capital, and Baillie Gifford”
“Chai Discovery raised $400M in Series C funding to advance AI-driven drug discovery.”
“When isomorphic's round was oversubscribed 8-10x, the capital that didn't get in created enormous investor pressure and interest that cascaded directly into Chai Discovery ($400M at $3.8B) and then further into Latent Labs in London. This is a repeatable, exploitable pattern.”
Source→“A very hot round got announced today, which was Chai Discovery. 400 million at a $3.8 billion valuation led by Index, Kleiner, Sequoia, Dimension.”
Source→“Chai Discovery...develops AI models that help drugmakers design molecules by predicting and reprogramming how molecules interact, raised a $400 million round at a $3.8 billion post-money valuation.”
Source→“San Francisco-based Chai Discovery, which builds AI models for molecular drug design, raised a $400 million Series C led by Index Ventures, Kleiner Perkins and Sequoia Capital at a $3.8 billion valuation.”
Source→“Chai Discovery raised $400 million at a $3.8 billion valuation, led by Index Ventures and joined by Kleiner Perkins, Sequoia, Bain Capital Ventures, Thrive Capital, and notably OpenAI itself.”
“Chai Discovery: AI-driven drug discovery / protein structure prediction company - Listed as a resource/reference”